Trademark Licensing Protection Act of 2019

S. 3952, the Protecting American Intellectual Property Act of 2020 H.R. 6058, the SHOP SAFE Act H.R. 6196/ S. 3449, the Trademark Modernization Act H.R. 8037, the Advancing America's Interests Act S. 4473/H.R. 7956, Critical Medical Infrastructure Right-to-Repair Act of 2020 S. 4138/H.R. 7448, Telework for U.S. Innovation Act S. 2987, the Counterfeit Goods Seizure Act of 2019 H.R. 5478, the Inventor Rights Act S. 2082/H.R. 3666, the STRONGER Patents Act of 2019 H.R. 4164/S. 2439, the Trademark Licensing Protection Act of 2019 S. 4394/H.R. 7890, the Inventor Diversity for Economic Advancement (IDEA) Act of 2020 S. 2281/H.R. 4075, the Inventor Diversity for Economic Advancement (IDEA) Act of 2019 H.R. 3954. Including the exclusive economic zone as part of the United States for patent infringement H.R. 3991, the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019 H.R. 3199, Terminating the Extension of Rights Misappropriated (TERM) Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 H.R. 2426/S. 1272, the CASE Act H.R. 1999/S. 963, the Fair Licensing Access for Governments (FLAG) Act of 2019 (entire bill) S. 376 /H.R. 1683, No Stolen Trademarks Honored in America Act (entire bill) S. 659, A bill to provide for certain additional requirements with respect to patent disclosures. (entire bill) S. 440, Preserving Access to Cost Effective Drugs Act (PACED) Act (entire bill) S. 344/H.R. 990, Hatch-Waxman Integrity Act of 2019 (entire bill) H.R. 108, Targeting Rogue and Opaque Letters Act of 2019 (entire bill) S. 64, Preserve Access to Affordable Generics and Biosimilars Act (entire bill) H.R.902, Protect American IPR Act (entire bill) Issues related to USPTO operations Legislative proposal on patent subject matter eligibility Issues related to Covered Business Method Patent Pilot Program Issues related to Copyright Office Modernization Issues related to sovereign immunity Issues related to the review of the Digital Millennium Copyright Act (DMCA)

Client expense: $10,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Library of Congress (LOC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)

Advocacy to expand union rights and representation for all workers, as well as labor protections. Oppose legislation to weakening union rights and protections Raise the Wage Act Paid sick leave HEROES Act, Senate COVID bill OSHA standards Paycheck guarantee HR 133 HR 4164 HR 6800 HR 2500 HR 1534 HR 2148 HR 1423 HR 1309 HR 582 S 150 HR 2474 S 1306 HR 3463/1970 HR 4164 S 1082 S 2439 S 4317 (Oppose Safe to Work Act) HR 6898 S 3768 S 4775 S 8337

Client expense: $259,593 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Discuss the distribution methodology for the Public Health and Social Services Emergency Fund with Congressional staff. Discuss issues related to Medicare accelerated payments with Congressional staff. Discuss legislative priorities with Congressional staff: a delay of cuts to Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Discuss the need to reform the United States' liver allocation system with Congressional staff/members. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff. Support surprise billing legislation reform and work with committee and Congressional staff on a range of issues. Discussed several bills including: Protecting People from Surprise Medical Bills Act (H.R. 3502), Lower Health Care Costs Act (S. 1895), No Surprises Act (H.R. 3630) and Consumer Protections Against Surprise Medical Bills Act of 2020 (H.R. 5826). Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Discuss provisions in the CARES Act (H.R. 748) related to health care provider liability and immunity with Congressional staff. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with congressional staff. Discuss drug shortages related to the COVID-19 crisis with Congressional and Administration staff. Discuss the HEROES Act (H.R. 6800) and other COVID-19 phase four response legislation with Congressional staff. Discuss disbursements from the Public Health and Social Services Emergency Fund with Congressional staff. Discuss Medicare Advance Payment forgiveness with Congressional staff. Discuss supply chain issues, including PPE and ventilators, with Congressional staff. Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff.

Client expense: $250,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation. Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439) and its inclusion in appropriations legislative.

Client expense: $250,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.1273 and H.R. 2426 CASE Act of 2019, specifically provision about impact on traditional court cases. S. 2439/ H.R. 4164 Trademark Licensing Protection Act of 2019. General lobbying with regard to patent infringement liability.

Client expense: $1,110,000 · Firm income: Not reported

Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), and the Affordable Care Act (support). Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff. Discuss the HEROES Act (H.R. 6800) and other COVID-19 phase four response legislation with lawmakers, Congressional staff, HHS and the White House. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 7292 (support). Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS.

Client expense: $550,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Bureau of Investigation (FBI), Federal Emergency Management Agency (FEMA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), President of the U.S., SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Support for the Medical liability provisions in the budget. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation. Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (n) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439), and its inclusion in appropriations legislative.

Client expense: $550,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Bureau of Investigation (FBI), Federal Emergency Management Agency (FEMA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), President of the U.S., SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Advocate for increasing borrowing limits on SBA loans and ensuring health care providers are eligible. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Discuss the distribution methodology for the Public Health and Social Services Emergency Fund with the White House, HHS, CMS and Congressional staff. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts to Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Support for the Medical liability provisions in the budget. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Support surprise billing legislation reform and work with committee and Congressional staff on a range of issues. Discussed several bills including: Protecting People from Surprise Medical Bills Act (H.R. 3502), Lower Health Care Costs Act (S. 1895), No Surprises Act (H.R. 3630) and Consumer Protections Against Surprise Medical Bills Act of 2020 (H.R. 5826). Discussed the inclusion of surprise billing legislation in COVID-19 response legislation. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss provisions in the CARES Act (H.R. 748) related to health care provider liability and immunity with Congressional and committee staff. Attend cybersecurity briefing related to foreign threats with FBI. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff. Discuss drug shortages related to the COVID-19 crisis with Congressional and Administration staff. Coordinate with ASPR, the Department of Defense, FEMA and the FDA on COVID-19 response efforts. Discuss the HEROES Act (H.R. 6800) and other COVID-19 phase four response legislation with lawmakers, Congressional staff, HHS and the White House. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss hospital infrastructure spending with Congressional staff, including in the Invest in America Act (H.R. 2). Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 7292 (support). Discuss supply chain issues, including PPE and ventilators, with Congressional staff, HHS and White House. Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff. Discuss surprise billing legislation with White House staff. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS.

Client expense: $550,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Bureau of Investigation (FBI), Federal Emergency Management Agency (FEMA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), President of the U.S., SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

Issues related to intellectual property; S.2439/H.R.4164, Trademark Licensing Protection Act of 2019.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, Treasury, Dept of

Issues related to trademark protection. Trademark licensing. H.R.4164/S.2439: Trademark Licensing Protection Act of 2019. H.R.6196/S.3449: Trademark (TM) Act of 2020. H.R.6058: SHOP SAFE Act of 2020.

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office

Advocacy to expand union rights and representation for all workers, as well as labor protections. Oppose legislation to weakening union rights and protections Paid sick leave HEROES Act, Senate COVID bill OSHA standards Paycheck guarantee HR 6800 S 1055 HR 1309 HR 6201 HR 748 S 3548 S 3793 HR 6918 HR 2500 HR 1534 HR 2148 HR 1423 HR 1309 HR 582 S 150 HR 2474 S 1306 HR 3463/1970 HR 4164 S 1082 S 2439 HR 2694 (Support Pregnant workers Fairness Act-workplace protections for pregnant workers) S 4317 (Safe to Work Act) HR 6898 S 3768 S 4775 S 8337

Client expense: $259,593 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to intellectual property; S.2439/H.R.4164, Trademark Licensing Protection Act of 2019.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, Treasury, Dept of

Issues related to trademark protection. Trademark licensing. H.R.4164/S.2439: Trademark Licensing Protection Act of 2019. H.R.6196/S.3449: Trademark (TM) Act of 2020. H.R.6058: SHOP SAFE Act of 2020.

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE

H.R. 6058, the SHOP SAFE Act H.R. 6196/ S. 3449, the Trademark Modernization Act H.R. 8037, the Advancing America's Interests Act S. 4473/H.R. 7956, Critical Medical Infrastructure Right-to-Repair Act of 2020 S. 4138/H.R. 7448, Telework for U.S. Innovation Act S. 2987, the Counterfeit Goods Seizure Act of 2019 H.R. 5478, the Inventor Rights Act S. 2082/H.R. 3666, the STRONGER Patents Act of 2019 H.R. 4164/S. 2439, the Trademark Licensing Protection Act of 2019 S. 4394/H.R. 7890, the Inventor Diversity for Economic Advancement (IDEA) Act of 2020 S. 2281/H.R. 4075, the Inventor Diversity for Economic Advancement (IDEA) Act of 2019 H.R. 3954. Including the exclusive economic zone as part of the United States for patent infringement H.R. 3991, the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019 H.R. 3199, Terminating the Extension of Rights Misappropriated (TERM) Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 H.R. 2426/S. 1272, the CASE Act H.R. 1999/S. 963, the Fair Licensing Access for Governments (FLAG) Act of 2019 (entire bill) S. 376 /H.R. 1683, No Stolen Trademarks Honored in America Act (entire bill) S. 659, A bill to provide for certain additional requirements with respect to patent disclosures. (entire bill) S. 440, Preserving Access to Cost Effective Drugs Act (PACED) Act (entire bill) S. 344/H.R. 990, Hatch-Waxman Integrity Act of 2019 (entire bill) H.R. 108, Targeting Rogue and Opaque Letters Act of 2019 (entire bill) S. 64, Preserve Access to Affordable Generics and Biosimilars Act (entire bill) H.R.902, Protect American IPR Act (entire bill) Issues related to USPTO operations Legislative proposal on patent subject matter eligibility Issues related to Covered Business Method Patent Pilot Program Issues related to Copyright Office Modernization Issues related to sovereign immunity Issues related to the review of the Digital Millennium Copyright Act (DMCA)

Client expense: Not reported · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Library of Congress (LOC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)

S.1273 and H.R. 2426 CASE Act of 2019, specifically provision about impact on traditional court cases. S. 2439/ H.R. 4164 Trademark Licensing Protection Act of 2019. General lobbying with regard to patent infringement liability.

Client expense: $1,400,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)

S. 2439, Trademark Licensing Protection Act H.R. 4146, Trademark Licensing Protection Act

Client expense: $180,000 · Firm income: Not reported

Government targets: Federal Accounting Standards Advisory Board (FASAB), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), Treasury, Dept of, White House Office

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), and the Affordable Care Act (support). Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff. Discuss the HEROES Act (H.R. 6800) and other COVID-19 phase four response legislation with lawmakers, Congressional staff, HHS and the White House. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 7292 (support). Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS.

Client expense: $550,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Bureau of Investigation (FBI), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), President of the U.S., SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Advocate for increasing borrowing limits on SBA loans and ensuring health care providers are eligible. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Discuss the distribution methodology for the Public Health and Social Services Emergency Fund with the White House, HHS, CMS and Congressional staff. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts to Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Support for the Medical liability provisions in the budget. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Support surprise billing legislation reform and work with committee and Congressional staff on a range of issues. Discussed several bills including: Protecting People from Surprise Medical Bills Act (H.R. 3502), Lower Health Care Costs Act (S. 1895), No Surprises Act (H.R. 3630) and Consumer Protections Against Surprise Medical Bills Act of 2020 (H.R. 5826). Discussed the inclusion of surprise billing legislation in COVID-19 response legislation. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss provisions in the CARES Act (H.R. 748) related to health care provider liability and immunity with Congressional and committee staff. Attend cybersecurity briefing related to foreign threats with FBI. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff. Discuss drug shortages related to the COVID-19 crisis with Congressional and Administration staff. Coordinate with ASPR, the Department of Defense, FEMA and the FDA on COVID-19 response efforts. Discuss the HEROES Act (H.R. 6800) and other COVID-19 phase four response legislation with lawmakers, Congressional staff, HHS and the White House. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss hospital infrastructure spending with Congressional staff, including in the Invest in America Act (H.R. 2). Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 7292 (support). Discuss supply chain issues, including PPE and ventilators, with Congressional staff, HHS and White House. Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff. Discuss surprise billing legislation with White House staff. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS.

Client expense: $550,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Bureau of Investigation (FBI), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), President of the U.S., SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Support for the Medical liability provisions in the budget. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation. Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (n) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439), and its inclusion in appropriations legislative.

Client expense: $550,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Bureau of Investigation (FBI), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), President of the U.S., SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

Issues related to trademark protection. Trademark Licensing. H.R.4164/S.2439: Trademark Licensing Protection Act. H.R.6196/S.3449: Trademark Modernization Act of 2020. H.R.6058: SHOP SAFE Act of 2020.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 2439, Trademark Licensing Protection Act H.R. 4146, Trademark Licensing Protection Act

Client expense: $190,000 · Firm income: Not reported

Government targets: Federal Accounting Standards Advisory Board (FASAB), Federal Reserve System, HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

S. 2439, Trademark Licensing Protection Act H.R. 4146, Trademark Licensing Protection Act

Client expense: $156,610 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

Advocacy to expand union rights and representation for all workers, as well as labor protections. Oppose legislation to weakening union rights and protections Paid sick leave OSHA standards Paycheck guarantee HR 6800 S 1055 HR 1309 HR 6201 HR 748 S 3548 S 3793 HR 6918 HR 2500 HR 1534 HR 2148 HR 1423 HR 1309 HR 582 S 150 HR 2474 S 1306 HR 3463/1970 HR 4164 S 1082 S 2439 S 1306 S 1082 S 2439 HR 4164

Client expense: $201,733 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 2439, Trademark Licensing Protection Act H.R. 4146, Trademark Licensing Protection Act

Client expense: $190,000 · Firm income: Not reported

Government targets: Federal Accounting Standards Advisory Board (FASAB), Federal Reserve System, HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

Issues related to intellectual property; S.2439/H.R.4164, Trademark Licensing Protection Act of 2019.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, Treasury, Dept of

S.1273 and H.R. 2426 CASE Act of 2019, specifically provision about impact on traditional court cases. S. 2439/ H.R. 4164 Trademark Licensing Protection Act of 2019. General lobbying with regard to patent infringement liability.

Client expense: $1,350,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation. Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (n) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439), and its inclusion in appropriations legislative.

Client expense: $260,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Discuss issues related to Medicare accelerated payments with Congressional staff. Discuss legislative priorities with Congressional staff: a delay of cuts Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), and the Affordable Care Act (support). Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with Congressional staff. Discuss the HEROES Act (H.R. 6800) and other COVID-19 phase four response legislation with Congressional staff. Discuss Medicare Advance Payment forgiveness with Congressional staff, advocated for H.R. 7292 (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation.

Client expense: $260,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Discuss issues related to Medicare accelerated payments with Congressional staff. Discuss legislative priorities with Congressional staff: a delay of cuts to Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Support surprise billing legislation reform and work with committee and Congressional staff on a range of issues. Discussed several bills including: Protecting People from Surprise Medical Bills Act (H.R. 3502), Lower Health Care Costs Act (S. 1895), No Surprises Act (H.R. 3630) and Consumer Protections Against Surprise Medical Bills Act of 2020 (H.R. 5826). Discussed the inclusion of surprise billing legislation in COVID-19 response legislation. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with Congressional staff. Discuss drug shortages related to the COVID-19 crisis with Congressional and Administration staff. Discuss the HEROES Act (H.R. 6800) and other COVID-19 phase four response legislation with lawmakers, Congressional staff, HHS and the White House. Discuss supply chain issues, including PPE and ventilators, with Congressional staff. Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff.

Client expense: $260,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 6058, the SHOP SAFE Act H.R. 6196/ S. 3449, the Trademark Modernization Act S. 2987, the Counterfeit Goods Seizure Act of 2019 H.R. 5478, the Inventor Rights Act S. 2082/H.R. 3666, the STRONGER Patents Act of 2019 H.R. 4164/S. 2439, the Trademark Licensing Protection Act of 2019 S. 2281/H.R. 4075, the Inventor Diversity for Economic Advancement (IDEA) Act of 2019 H.R. 3954. Including the exclusive economic zone as part of the United States for patent infringement H.R. 3991, the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019 H.R. 3199, Terminating the Extension of Rights Misappropriated (TERM) Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 H.R. 2426/S. 1272, the CASE Act H.R. 1999/S. 963, the Fair Licensing Access for Governments (FLAG) Act of 2019 (entire bill) S. 376 /H.R. 1683, No Stolen Trademarks Honored in America Act (entire bill) S. 659, A bill to provide for certain additional requirements with respect to patent disclosures. (entire bill) S. 440, Preserving Access to Cost Effective Drugs Act (PACED) Act (entire bill) S. 344/H.R. 990, Hatch-Waxman Integrity Act of 2019 (entire bill) H.R. 108, Targeting Rogue and Opaque Letters Act of 2019 (entire bill) S. 64, Preserve Access to Affordable Generics and Biosimilars Act (entire bill) H.R.902, Protect American IPR Act (entire bill) Issues related to USPTO operations Legislative proposal on patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to sovereign immunity Issues related to the review of the Digital Millennium Copyright Act (DMCA)

Client expense: Not reported · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Library of Congress (LOC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Advocate for increasing borrowing limits on SBA loans and ensuring health care providers are eligible. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Discuss the distribution methodology for the Public Health and Social Services Emergency Fund with the White House, HHS, CMS and Congressional staff. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts to Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Support for the Medical liability provisions in the budget. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Support surprise billing legislation reform and work with committee and Congressional staff on a range of issues. Discussed several bills including: Protecting People from Surprise Medical Bills Act (H.R. 3502), Lower Health Care Costs Act (S. 1895), No Surprises Act (H.R. 3630) and Consumer Protections Against Surprise Medical Bills Act of 2020 (H.R. 5826). Discussed the inclusion of surprise billing legislation in COVID-19 response legislation. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss provisions in the CARES Act (H.R. 748) related to health care provider liability and immunity with Congressional and committee staff. Attend cybersecurity briefing related to foreign threats with FBI. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff. Discuss drug shortages related to the COVID-19 crisis with Congressional and Administration staff. Coordinate with ASPR, the Department of Defense, FEMA and the FDA on COVID-19 response efforts. Discuss the HEROES Act (H.R. 6800) and other COVID-19 phase four response legislation with lawmakers, Congressional staff, HHS and the White House. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss hospital infrastructure spending with Congressional staff, including in the Invest in America Act (H.R. 2). Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 7292 (support). Discuss supply chain issues, including PPE and ventilators, with Congressional staff, HHS and White House. Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff. Discuss surprise billing legislation with White House staff. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS.

Client expense: $570,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Bureau of Investigation (FBI), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), President of the U.S., SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Support for the Medical liability provisions in the budget. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation. Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (n) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439), and its inclusion in appropriations legislative.

Client expense: $570,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Bureau of Investigation (FBI), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), President of the U.S., SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), and the Affordable Care Act (support). Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff. Discuss the HEROES Act (H.R. 6800) and other COVID-19 phase four response legislation with lawmakers, Congressional staff, HHS and the White House. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 7292 (support). Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS.

Client expense: $570,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Bureau of Investigation (FBI), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), President of the U.S., SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

35 USC section 101 reform - subject matter eligibility reform PTO guidance on section 112 and section 101 Copyright Alternative in Small Claims Enforcement Act of 2019 (CASE Act 2019) S. 1273 and HR 2426 Fraudulent Trademark applications and registrations Trademark Licensing Protection Act (S. 2439) Trademark Modernization Act of 2020 (HR 6146 and S.3449) PTAB constitutional issues post Arthrex v. Smith & Noble Copyright Modernization Selection of the new Copyright Register Coronavirus Aid, Relief, and Economic Security (CARES) Act (HR 748 and S. 3548) sections 12004 and 19011 SHOPSAFE Act (HR 6058)

Client expense: Not reported · Firm income: $5,000

Government targets: HOUSE OF REPRESENTATIVES, Library of Congress (LOC), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office

H.R. 4164: TRADEMARK LICENSING PROTECTION ACT OF 2019; ALL PROVISIONS OF THE BILL S. 2439: TRADEMARK LICENSING PROTECTION ACT OF 2019; ALL PROVISIONS OF THE BILL

Client expense: $250,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, White House Office

Advocacy to expand union rights and representation for all workers, as well as labor protections. Oppose legislation to weakening union rights and protections Paid sick leave OSHA standards Sexual harassment on the job Bill to ensure public sector workers have the right to join a union and collectively bargain Unemployment insurance HR 2474 HR 2148/S 1082 HR 3463/1970 HR 4164 HR 1423 HR 1309 HR 582 S 150 S 1306 S 1082 S 2439 HR 4164 HR 2500 HR 1534

Client expense: $225,861 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 2439, Trademark Licensing Protection Act H.R. 4146, Trademark Licensing Protection Act

Client expense: $156,610 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

S.1273 and H.R. 2426 CASE Act of 2019, specifically provision about impact on traditional court cases. S. 2439/ H.R. 4164 Trademark Licensing Protection Act of 2019. General lobbying with regard to patent infringement liability.

Client expense: $1,370,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)

H.R. 6058, the SHOP SAFE Act H.R. 6196/ S. 3449, the Trademark Modernization Act S. 2987, the Counterfeit Goods Seizure Act of 2019 H.R. 5478, the Inventor Rights Act S. 2082/H.R. 3666, the STRONGER Patents Act of 2019 H.R. 4164/S. 2439, the Trademark Licensing Protection Act of 2019 S. 2281/H.R. 4075, the Inventor Diversity for Economic Advancement (IDEA) Act of 2019 H.R. 3954. Including the exclusive economic zone as part of the United States for patent infringement H.R. 3991, the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019 H.R. 3199, Terminating the Extension of Rights Misappropriated (TERM) Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 H.R. 2426/S. 1272, the CASE Act H.R. 1999/S. 963, the Fair Licensing Access for Governments (FLAG) Act of 2019 (entire bill) S. 376 /H.R. 1683, No Stolen Trademarks Honored in America Act (entire bill) S. 659, A bill to provide for certain additional requirements with respect to patent disclosures. (entire bill) S. 440, Preserving Access to Cost Effective Drugs Act (PACED) Act (entire bill) S. 344/H.R. 990, Hatch-Waxman Integrity Act of 2019 (entire bill) H.R. 108, Targeting Rogue and Opaque Letters Act of 2019 (entire bill) S. 64, Preserve Access to Affordable Generics and Biosimilars Act (entire bill) H.R.902, Protect American IPR Act (entire bill) Issues related to USPTO operations Legislative proposal on patent subject matter eligibility Issues related to Copyright Office Modernization

Client expense: $10,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Library of Congress (LOC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)

Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Support for the Medical liability provisions in the budget. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation. Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (n) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439), and its inclusion in appropriations legislative.

Client expense: $630,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Bureau of Investigation (FBI), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), President of the U.S., SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), and the Affordable Care Act (support). Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff.

Client expense: $630,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Bureau of Investigation (FBI), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), President of the U.S., SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Advocate for increasing borrowing limits on SBA loans and ensuring health care providers are eligible. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Discuss the distribution methodology for the Public Health and Social Services Emergency Fund with the White House, HHS, CMS and Congressional staff. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts to Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Support for the Medical liability provisions in the budget. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Support surprise billing legislation reform and work with committee and Congressional staff on a range of issues. Discussed several bills including: Protecting People from Surprise Medical Bills Act (H.R. 3502), Lower Health Care Costs Act (S. 1895), No Surprises Act (H.R. 3630) and Consumer Protections Against Surprise Medical Bills Act of 2020 (H.R. 5826). Discussed the inclusion of surprise billing legislation in COVID-19 response legislation. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss provisions in the CARES Act (H.R. 748) related to health care provider liability and immunity with Congressional and committee staff. Attend cybersecurity briefing related to foreign threats with FBI. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff. Discuss drug shortages related to the COVID-19 crisis with Congressional and Administration staff. Coordinate with ASPR, the Department of Defense, FEMA and the FDA on COVID-19 response efforts.

Client expense: $630,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Bureau of Investigation (FBI), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), President of the U.S., SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office

Issues related to intellectual property; S.2439/H.R.4164, Trademark Licensing Protection Act of 2019.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, Treasury, Dept of

35 USC section 101 reform - subject matter eligibility reform PTO guidance on section 112 and section 101 Copyright Alternative in Small Claims Enforcement Act of 2019 (CASE Act 2019) S. 1273 and HR 2426 Fraudulent Trademark applications and registrations Trademark Licensing Protection Act (S. 2439) Trademark Modernization Act of 2020 (HR 6146 and S.3449) PTAB constitutional issues post Arthrex v. Smith & Noble Copyright Modernization Selection of the new Copyright Register Coronavirus Aid, Relief, and Economic Security (CARES) Act (HR 748 and S. 3548) sections 12004 and 19011

Client expense: Not reported · Firm income: $7,500

Government targets: HOUSE OF REPRESENTATIVES, Library of Congress (LOC), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office